Related Experiment Video
Updated: Dec 12, 2025

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
The Mechanism of Contrast-Induced Acute Kidney Injury and Its Association with Diabetes Mellitus
1Department of Radiology, Xiang'an Hospital of Xiamen University, Xiamen 361102, China.
Insights
Diabetes mellitus and its kidney complication, diabetic nephropathy, increase the risk of contrast-induced acute kidney injury (CI-AKI). This review explores how high glucose status, immune responses, and signaling pathways contribute to CI-AKI in diabetic patients.
Area of Science:
- Nephrology
- Endocrinology
- Immunology
Background:
- Contrast-induced acute kidney injury (CI-AKI) is a significant hospital-acquired condition with adverse effects on patient prognosis, hospital stay, and costs.
- Diabetic nephropathy (DN), a complication of diabetes mellitus (DM), is an independent risk factor for chronic kidney disease (CKD) and CI-AKI.
- The incidence of CI-AKI is notably higher in patients with pre-existing renal injury, particularly those with DN.
Purpose of the Study:
- To elucidate the mechanisms by which diabetes mellitus facilitates CI-AKI.
- To review the pathophysiological, immunological, and signaling pathway aspects linking high-glucose status and CI-AKI.
Main Methods:
- Review of existing literature on CI-AKI, diabetes mellitus, and diabetic nephropathy.
- Analysis of pathophysiological changes in the kidney under high-glucose status (HGS).
- Examination of immunological alterations in DM/DN that promote CI-AKI.
- Investigation of signaling pathways common to both CI-AKI and DM.
Main Results:
- High-glucose status exacerbates oxidative stress, increases reactive oxygen species (ROS), causes vasoconstriction, and impairs kidney oxygen supply, creating a detrimental cycle with CI-AKI.
- Immune responses in DM/DN, involving innate immune cells and pattern recognition receptors (PRRs), may interact with damage-associated molecular patterns (DAMPs) during CI-AKI.
- Signaling pathways implicated in CI-AKI are associated with apoptosis, inflammation, and ROS production, suggesting potential therapeutic targets.
Conclusions:
- Diabetes mellitus significantly predisposes individuals to CI-AKI through complex pathophysiological and immunological mechanisms.
- Understanding the interplay between high glucose, kidney injury, and immune activation is crucial.
- Further research into shared signaling pathways is needed to develop novel strategies for preventing and treating CI-AKI in diabetic patients.
Abstract:
Contrast-induced acute kidney injury (CI-AKI) is the third most common hospital-acquired AKI after AKI induced by renal perfusion insufficiency and nephrotoxic drugs, taking great adverse effects on the prognosis and increasing hospital stay and medical cost. Diabetes nephropathy (DN) is a common chronic complication of DM (diabetes mellitus), and DN is an independent risk factor for chronic kidney disease (CKD) and CI-AKI. The incidence of CI-AKI significantly increases in patients with renal injury, especially in DM-related nephropathy. The etiology of CI-AKI is not fully clear, and research studies on how DM becomes a facilitated factor of CI-AKI are limited. This review describes the mechanism from three aspects. ① Pathophysiological changes of CI-AKI in kidney under high-glucose status (HGS). HGS can enhance the oxidative stress and increase ROS which next causes stronger vessel constriction and insufficient oxygen supply in kidney via vasoactive substances. HGS also aggravates some ion pump load and the latter increases oxygen consumption. CI-AKI and HGS are mutually causal, making the kidney function continue to decline. ② Immunological changes of DM promoting CI-AKI. Some innate immune cells and pattern recognition receptors (PRRs) in DM and/or DN may respond to some damage-associated molecular patterns (DAMPs) formed by CI-AKI. These effects overlap with some pathophysiological changes in hyperglycemia. ③ Signaling pathways related to both CI-AKI and DM. These pathways involved in CI-AKI are closely associated with apoptosis, inflammation, and ROS production, and some studies suggest that these pathways may be potential targets for alleviating CI-AKI. In conclusion, the pathogenesis of CI-AKI and the mechanism of DM as a predisposing factor for CI-AKI, especially signaling pathways, need further investigation to provide new clinical approaches to prevent and treat CI-AKI.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease I: Introduction

